Can avatrombopag (Sucoxin) continuously and stably increase platelet levels?

Avatrombopag (Avatrombopag) is an oral thrombopoietin receptor agonist (TPO-RA). By simulating the effect of thrombopoietin (TPO), it activates the proliferation and differentiation of bone marrow megakaryocytes, thereby promoting platelet production. It is mainly used to treat patients with thrombocytopenia associated with chronic liver disease and idiopathic thrombocytopenic purpura (ITP). Compared with traditional blood transfusions or short-acting drugs, avatrombopag can be taken orally to maintain platelet levels, making it easier to manage long-term.

Clinical studies have shown that avatrombopag can significantly increase platelet counts in the treatment of patients with chronic thrombocytopenia, with most patients experiencing an increase in platelet levels within 1–2 weeks after the start of treatment. Long-term use can maintain platelets within a safe range, reduce the risk of bleeding, and reduce dependence on blood transfusions or acute intervention. At the same time, the rate of platelet increase is relatively stable and it is not prone to sudden platelet fluctuations, making it suitable for long-term maintenance treatment.

Avatrombopag is generally well tolerated. Common side effects are mild headache, fatigue or gastrointestinal discomfort, and the incidence of serious adverse events is low. Compared with other TPO receptor agonists, it is easy to take orally and has smaller platelet fluctuations, helping to continuously and stably maintain platelet levels. During long-term use, platelet count, liver and kidney function, and thrombosis risk need to be monitored regularly to ensure efficacy and safety.

In actual clinical practice, the dose of avatrombopag can be adjusted individually based on the patient's basic platelet level and bleeding risk. For patients with chronic thrombocytopenia, doctors can achieve stable maintenance of platelet levels by gradually adjusting the dose and monitoring regularly. During long-term medication, patients should follow medical advice, undergo regular check-ups, and pay attention to preventing trauma or other factors that may cause bleeding to ensure sustained and stable efficacy.

Reference materials:https://www.drugs.com/